28 April 2009

First Quarter 2009 Financial Highlights

Ossur hf.
Reykjavik,
28 April 2009

First Quarter 2009 Financial Highlights

Sales USD 77.2 million, down by 13%, down by 4% measured in LCY 

EBITDA USD 12.9 million, down by 26%*

EBITDA margin 17%, compared to 20%* in Q1 2008

Net profit USD 7.6 million, compared to USD 6.7 million in Q1 2008

EPS diluted 1.79 US cents, compared to 1.58 US cents in Q1 2008

Cash EPS diluted 2.98 US cents, the same as in Q1 2008
 

Press Release 

Financial Statement 1Q 2009 

Investor Presentation   

  

Jon Sigurdsson, President & CEO, comments:

 “The first quarter shows slower sales than anticipated, declining by 4% measured in local currency. Sales in the first quarter are affected by the slowdown in the economy, in all our major markets. Sales in prosthetics are in line with the market whereas sales of bracing and supports in the Americas continue to be challenging. We have made some extensive changes in the leadership in the sales and marketing in the Americas which we believe will return positive results for this segment. In 2009 we have an exciting product pipeline and in the first quarter two new products were introduced.”  

*NOTE: Excluding one-time gain in Q1 2008


Go back